NASDAQ
No price data available for this timeframe.
AnaptysBio, Inc. (ANAB) has a price/sales ratio of 3.83x as of Friday, May 22, 2026. This represents a 83.32% decrease compared to its 12-month average of 22.95x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.